Ageing immune systems are undermining Europe’s vaccination programmes, longevity experts warn
6 Nov, 2025
A new report, 'Supporting our systems: Addressing immunosenescence and improving adult immunisation in Europe', highlights that the natural decline of the immune system with age – a process called immunosenescence – is a critical threat to the effectiveness of adult vaccination programmes across the continent.
Immunosenescence, which typically accelerates from the age of 50 onwards, makes older people more susceptible to infectious diseases and can reduce their immune response to vaccines. With one in five Europeans now aged 65 or over, the report warns that if we don’t address these issues, this trend could undermine the effectiveness of current immunisation programmes and mean they’re less likely to prevent hospitalisation and severe disease.
The report, informed by interviews with public health experts and analysis of European data, highlights how this mismatch between science and policy leaves millions of people vulnerable.
- Vaccine responses in older adults are often shorter-lived and less robust than in younger groups.
- Across Europe, only 47% of people aged 65 and over received a flu vaccine in 2022 – leaving around 60 million older people unprotected.
- Pneumococcal vaccination rates are even lower, averaging just 24% in the ten countries with available data.
Health inequalities compound the problem. There is almost a decade (9.5 years) between the highest and lowest healthy life expectancy across Europe. Countries in Eastern Europe tend to have both lower healthy life expectancy and higher rates of long-term conditions. People in poorer regions, therefore, face a double disadvantage – they are more likely to become ill earlier and less likely to access preventative care such as vaccination.
To close these gaps and help people stay healthy for longer, the report calls on national governments and EU institutions to act. Governments should:
- Lower the age for routine vaccination programmes, such as fl,u to around 50, or in line with national healthy life expectancy, so people are vaccinated while their immune systems are still capable of a strong response (see chart below)
- Invest more in using and supporting the development of enhanced vaccines that deliver better health outcomes for older adults
- Increase the proportion of health budgets spent on immunisation and commit to spending at least 8% of healthcare budgets on prevention.
Addressing inequalities will require working closely with local communities and civil society organisations to improve access in underserved and socio-economically deprived areas. Public health bodies should also strengthen communication and provide better training for healthcare professionals to build confidence in vaccination and explain its importance for healthy ageing.
Finally, the European Parliament should establish a new Sub-Committee on Healthy Ageing to lead a coordinated European approach.
By acting earlier, investing in better vaccines, and tackling inequality, Europe can help ensure more people live longer, healthier lives protected from preventable disease.
David Sinclair, ILC-UK’s Chief Executive, said:
“As we age, our immune systems weaken, leaving us more vulnerable to diseases that vaccines could otherwise prevent. Yet our policies are still too often built around rigid age thresholds rather than the reality of how our bodies change over time.
“We need to invest in the science that helps us understand how our immune systems age, and in the preventative interventions that keep them strong. That means moving away from one-size-fits-all vaccination schedules, targeting protection where it’s needed most, and ensuring that older adults aren’t left behind.
“Good health in later life isn’t just about living longer – it’s about living better. Keeping people healthy helps them to work, volunteer, care and contribute. Investing in prevention and tailored science isn’t a luxury – it’s essential if we want to unlock the economic and social benefits of longevity.”
John-Kenneth Billingsley, Head of International Government Affairs, Policy & Advocacy, CSL Seqirus, said:
“Immunosenescence is something that impacts all of us as we age, and national and EU policymakers must invest in vaccination and preventive health strategies to ensure we achieve healthy ageing across Europe.
“By taking measures now to protect and promote the health of our ageing populations, we can curb the impact posed by declining immune function and enable people to live longer, healthier lives.”
Ends
Contact
Contact press@ilcuk.org.uk for press queries. Spokespeople are available for interview.
Notes to editors
The project was sponsored by CSL Seqirus. ILC-UK retained full editorial control.
Some countries find it more effective to lower their vaccination age recommendations in line with their average healthy life expectancy (HLE).
- In Bulgaria, for example, flu vaccination is recommended for people aged 45 and over, while the HLE is 63.1 years. Bulgarians who are vaccinated against the flu at 45 can expect to live another 18.1 years in good health, which potentially allows for a better immune response.
- In contrast, Lithuania’s age-based recommendation is for flu vaccination to begin at aged 65 but has an average HLE of 65 meaning the average window of time living in good health would have ends at the point of vaccination making it less likely to elicit the optimal immune response.
Average HLE in the UK is 70.5, yet the NHS recommends flu vaccination at 65, meaning there is a 5.5-year gap between the age at which someone becomes entitled to receive a free flu vaccination on the NHS and the age at which they can expect to live a “healthy” life.
Gap between flu vaccination recommendation age and healthy life expectancy (years)

About ILC
ILC is the UK’s leading authority on the impact of longevity on society. We combine evidence, solutions and networks to make change happen.
We help governments, policymakers, businesses and employers develop and implement solutions to ensure we all live happier, healthier and more fulfilling lives.
We want a society where tomorrow is better than today and where future generations are better off. ILC wants to help forge a new vision for the 100-year life where everyone has the opportunity to learn across our lives and where new technology helps us contribute more to society.
